Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joop van den Bergh

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|November 8, 2013
Bone erosions in rheumatoid arthritisPiet Geusens, Joop van den Bergh
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 22, 2026
Is Zoledronic acid cost-saving in daily practice?Willem Lems, Joop van den Bergh, Caroline Wyers
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Can Hip Fracture Prediction in Women be Estimated beyond Bone Mineral Density Measurement Alone?Piet Geusens, Tineke van Geel, Joop van den Bergh
Nederlands Tijdschrift Voor Geneeskunde|May 21, 2010
[Should the vitamin D level be determined for all fracture patients?]Joop van den Bergh, Tineke van Geel, Piet Geusens
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 12, 2019
Complementarity of Cohort Studies and Randomized Controlled TrialsJohn A Eisman, Piet Geusens, Joop van den Bergh
Expert Opinion on Pharmacotherapy|December 6, 2025
How to optimize the use of anti-osteoporotic medication in clinical practice?Willem F Lems, Piet Geusens, Joop van den Bergh
Expert Opinion on Biological Therapy|November 28, 2022
Romosozumab for the treatment of postmenopausal women at high risk of fracturePiet Geusens, Natasha Appelman-Dijkstra, Willem Lems, et al.
Expert Opinion on Drug Discovery|November 24, 2025
The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracturePiet Geusens, Wim Van Hul, Joop van den Bergh, et al.
European Journal of Pediatrics|September 19, 2003
Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short statureSimone Kapteijns-van Kordelaar, Kees Noordam, Barto Otten, et al.
Autism Research : Official Journal of the International Society for Autism Research|June 3, 2021
Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disordersRichard Houghton, Joop van den Bergh, Kiely Law, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|November 8, 2013
Bone erosions in rheumatoid arthritisPiet Geusens, Joop van den Bergh
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 22, 2026
Is Zoledronic acid cost-saving in daily practice?Willem Lems, Joop van den Bergh, Caroline Wyers
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Can Hip Fracture Prediction in Women be Estimated beyond Bone Mineral Density Measurement Alone?Piet Geusens, Tineke van Geel, Joop van den Bergh
Nederlands Tijdschrift Voor Geneeskunde|May 21, 2010
[Should the vitamin D level be determined for all fracture patients?]Joop van den Bergh, Tineke van Geel, Piet Geusens
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 12, 2019
Complementarity of Cohort Studies and Randomized Controlled TrialsJohn A Eisman, Piet Geusens, Joop van den Bergh
Expert Opinion on Pharmacotherapy|December 6, 2025
How to optimize the use of anti-osteoporotic medication in clinical practice?Willem F Lems, Piet Geusens, Joop van den Bergh
Expert Opinion on Biological Therapy|November 28, 2022
Romosozumab for the treatment of postmenopausal women at high risk of fracturePiet Geusens, Natasha Appelman-Dijkstra, Willem Lems, et al.
Expert Opinion on Drug Discovery|November 24, 2025
The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracturePiet Geusens, Wim Van Hul, Joop van den Bergh, et al.
European Journal of Pediatrics|September 19, 2003
Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short statureSimone Kapteijns-van Kordelaar, Kees Noordam, Barto Otten, et al.
Autism Research : Official Journal of the International Society for Autism Research|June 3, 2021
Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disordersRichard Houghton, Joop van den Bergh, Kiely Law, et al.
Pageof 4